James Rochon
Impact in
- Pharmacology top 0.1%
- Drug-Induced Hepatotoxicity and Protection
- Aging top 0.5%
Papers in
-
- Statistical Methods in Clinical Trials 11
- Statistical Methods and Bayesian Inference 11
- Statistical Methods and Inference 9
- Co-authors
- Robert J. FontanaPaul B. WatkinsTimothy J. DavernHerbert L. BonkovskyJosé SerranoJohn WD McDonaldRichard N. FedorakE. Jan Irvine
- Journals
- Gastroenterology (5 papers)Preventive Medicine (4 papers)Journal of the American Statistical Association (4 papers)Biometrics (4 papers)Journal of Biopharmaceutical Statistics (3 papers)
- Partner nations
- United StatesCanadaItaly
In The Last Decade
James Rochon
81 papers receiving 8.8k citations
Hit Papers
Peers
Comparison fields: 5 of 164
- Pharmacology 1.4k
- Aging 277
- Physiology 2.9k
- Public Health, Environmental and Occupational Health 2.0k
- Epidemiology 2.1k
Countries citing papers authored by James Rochon
This map shows the geographic impact of James Rochon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Rochon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Rochon more than expected).
Fields of papers citing papers by James Rochon
This network shows the impact of papers produced by James Rochon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Rochon. The network helps show where James Rochon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James Rochon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2 years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial Hit paper breakdown → | 2019 | 271 |
| 2 | 2017 | 38 | |
| 3 | 2016 | 42 | |
| 4 | 2011 | 98 | |
| 5 | 2010 | 146 | |
| 6 | 2009 | 368 | |
| 7 | 2008 | 134 | |
| 8 | 2006 | 8 | |
| 9 | 2005 | 80 | |
| 10 | 2004 | 78 | |
| 11 | 2004 | 56 | |
| 12 | 2004 | 32 | |
| 13 | 2004 | 58 | |
| 14 | 2003 | 3 | |
| 15 | 2002 | 3 | |
| 16 | 1995 | 22 | |
| 17 | Methotrexate for the Treatment of Crohn's Disease Hit paper breakdown → | 1995 | 651 |
| 18 | 1992 | 25 | |
| 19 | 1992 | 5 | |
| 20 | 1991 | 48 |
About James Rochon
James Rochon is a scholar working on Transplantation, Statistics and Probability, Aging, Pharmacology and Physiology, having authored 83 papers that have together received 9.1k indexed citations. Recurring topics across this work include Obesity, Physical Activity, Diet (14 papers), Diet and metabolism studies (13 papers), Drug-Induced Hepatotoxicity and Protection (12 papers), Statistical Methods in Clinical Trials (11 papers), Statistical Methods and Bayesian Inference (11 papers), Statistical Methods and Inference (9 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Dietary Effects on Health (7 papers). The work is most often cited by research in Pharmacology (1.4k citations), Aging (277 citations), Physiology (2.9k citations), Public Health, Environmental and Occupational Health (2.0k citations) and Epidemiology (2.1k citations). James Rochon has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Robert J. Fontana, Paul B. Watkins, Timothy J. Davern, Herbert L. Bonkovsky, José Serrano, John WD McDonald, Richard N. Fedorak, E. Jan Irvine, Brian G. Feagan and James R. Bain. Their work appears in journals such as Gastroenterology, Preventive Medicine, Journal of the American Statistical Association, Biometrics and Journal of Biopharmaceutical Statistics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.